110 related articles for article (PubMed ID: 18540355)
1. [Molecular biomarkers for prediction of multiple sclerosis relapse].
Satoh J
Nihon Rinsho; 2008 Jun; 66(6):1103-11. PubMed ID: 18540355
[TBL] [Abstract][Full Text] [Related]
2. Global map of physical interactions among differentially expressed genes in multiple sclerosis relapses and remissions.
Tuller T; Atar S; Ruppin E; Gurevich M; Achiron A
Hum Mol Genet; 2011 Sep; 20(18):3606-19. PubMed ID: 21676896
[TBL] [Abstract][Full Text] [Related]
3. [Interferon -beta therapy in multiple sclerosis].
Satoh J
Nihon Rinsho; 2006 Jul; 64(7):1297-309. PubMed ID: 16838648
[TBL] [Abstract][Full Text] [Related]
4. T cell gene expression profiling identifies distinct subgroups of Japanese multiple sclerosis patients.
Satoh J; Nakanishi M; Koike F; Onoue H; Aranami T; Yamamoto T; Kawai M; Kikuchi S; Nomura K; Yokoyama K; Ota K; Saito T; Ohta M; Miyake S; Kanda T; Fukazawa T; Yamamura T
J Neuroimmunol; 2006 May; 174(1-2):108-18. PubMed ID: 16564577
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling in multiple sclerosis: a disease of the central nervous system, but with relapses triggered in the periphery?
Brynedal B; Khademi M; Wallström E; Hillert J; Olsson T; Duvefelt K
Neurobiol Dis; 2010 Mar; 37(3):613-21. PubMed ID: 19944761
[TBL] [Abstract][Full Text] [Related]
6. Impaired expression of peripheral blood apoptotic-related gene transcripts in acute multiple sclerosis relapse.
Achiron A; Feldman A; Mandel M; Gurevich M
Ann N Y Acad Sci; 2007 Jun; 1107():155-67. PubMed ID: 17804543
[TBL] [Abstract][Full Text] [Related]
7. [Recent progress in bioinformatics for microarray analysis].
Satoh J
Yakugaku Zasshi; 2008 Nov; 128(11):1537-45. PubMed ID: 18981687
[TBL] [Abstract][Full Text] [Related]
8. Molecular network analysis of T-cell transcriptome suggests aberrant regulation of gene expression by NF-kappaB as a biomarker for relapse of multiple sclerosis.
Satoh J; Misawa T; Tabunoki H; Yamamura T
Dis Markers; 2008; 25(1):27-35. PubMed ID: 18776589
[TBL] [Abstract][Full Text] [Related]
9. [Tailored therapy for multiple sclerosis].
Misawa T; Mizusawa H
Nihon Rinsho; 2008 Jun; 66(6):1135-9. PubMed ID: 18540359
[TBL] [Abstract][Full Text] [Related]
10. pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity.
Frisullo G; Angelucci F; Caggiula M; Nociti V; Iorio R; Patanella AK; Sancricca C; Mirabella M; Tonali PA; Batocchi AP
J Neurosci Res; 2006 Oct; 84(5):1027-36. PubMed ID: 16865709
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease.
Bomprezzi R; Ringnér M; Kim S; Bittner ML; Khan J; Chen Y; Elkahloun A; Yu A; Bielekova B; Meltzer PS; Martin R; McFarland HF; Trent JM
Hum Mol Genet; 2003 Sep; 12(17):2191-9. PubMed ID: 12915464
[TBL] [Abstract][Full Text] [Related]
12. Blood transcriptional signatures of multiple sclerosis: unique gene expression of disease activity.
Achiron A; Gurevich M; Friedman N; Kaminski N; Mandel M
Ann Neurol; 2004 Mar; 55(3):410-7. PubMed ID: 14991819
[TBL] [Abstract][Full Text] [Related]
13. Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis.
Satoh J; Nakanishi M; Koike F; Miyake S; Yamamoto T; Kawai M; Kikuchi S; Nomura K; Yokoyama K; Ota K; Kanda T; Fukazawa T; Yamamura T
Neurobiol Dis; 2005 Apr; 18(3):537-50. PubMed ID: 15755681
[TBL] [Abstract][Full Text] [Related]
14. The switch between relapse and remission in multiple sclerosis: continuous inflammatory response balanced by Th1 suppression and neurotrophic factors.
Gurevich M; Achiron A
J Neuroimmunol; 2012 Nov; 252(1-2):83-8. PubMed ID: 22921736
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.
Begolka WS; Vanderlugt CL; Rahbe SM; Miller SD
J Immunol; 1998 Oct; 161(8):4437-46. PubMed ID: 9780223
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkers.
Martinelli-Boneschi F; Fenoglio C; Brambilla P; Sorosina M; Giacalone G; Esposito F; Serpente M; Cantoni C; Ridolfi E; Rodegher M; Moiola L; Colombo B; De Riz M; Martinelli V; Scarpini E; Comi G; Galimberti D
Neurosci Lett; 2012 Feb; 508(1):4-8. PubMed ID: 22108567
[TBL] [Abstract][Full Text] [Related]
17. Gene expression analysis of the microvascular compartment in multiple sclerosis using laser microdissected blood vessels.
Cunnea P; McMahon J; O'Connell E; Mashayekhi K; Fitzgerald U; McQuaid S
Acta Neuropathol; 2010 May; 119(5):601-15. PubMed ID: 19967542
[TBL] [Abstract][Full Text] [Related]
18. Zinc-ion binding and cytokine activity regulation pathways predicts outcome in relapsing-remitting multiple sclerosis.
Achiron A; Gurevich M; Snir Y; Segal E; Mandel M
Clin Exp Immunol; 2007 Aug; 149(2):235-42. PubMed ID: 17488294
[TBL] [Abstract][Full Text] [Related]
19. Intravenous polyclonal human immunoglobulins in multiple sclerosis.
Soelberg Sorensen P
Neurodegener Dis; 2008; 5(1):8-15. PubMed ID: 18075269
[TBL] [Abstract][Full Text] [Related]
20. Aberrant transcriptional regulatory network in T cells of multiple sclerosis.
Satoh J; Illes Z; Peterfalvi A; Tabunoki H; Rozsa C; Yamamura T
Neurosci Lett; 2007 Jul; 422(1):30-3. PubMed ID: 17629622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
